Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Intangibles (2016 - 2025)

Haemonetics has reported Intangibles over the past 16 years, most recently at $419.7 million for Q4 2025.

  • Quarterly results put Intangibles at $419.7 million for Q4 2025, down 9.85% from a year ago — trailing twelve months through Dec 2025 was $419.7 million (down 9.85% YoY), and the annual figure for FY2025 was $455.7 million, up 12.22%.
  • Intangibles for Q4 2025 was $419.7 million at Haemonetics, down from $428.4 million in the prior quarter.
  • Over the last five years, Intangibles for HAE hit a ceiling of $494.9 million in Q2 2024 and a floor of $250.5 million in Q3 2023.
  • Median Intangibles over the past 5 years was $359.6 million (2021), compared with a mean of $370.1 million.
  • Biggest five-year swings in Intangibles: skyrocketed 174.58% in 2021 and later dropped 15.11% in 2022.
  • Haemonetics' Intangibles stood at $337.2 million in 2021, then decreased by 15.68% to $284.4 million in 2022, then surged by 50.95% to $429.3 million in 2023, then increased by 8.47% to $465.6 million in 2024, then fell by 9.85% to $419.7 million in 2025.
  • The last three reported values for Intangibles were $419.7 million (Q4 2025), $428.4 million (Q3 2025), and $450.6 million (Q2 2025) per Business Quant data.